Cardioprotective action of metformin in experimental isoproterenol-induced myocardial infarction
Summary. Myocardial infarction (MI) occurs more frequently in patients with diabetes mellitus (DM) than in the general population and is characterized by a less favorable prognosis. Metformin is a first-line drug for the treatment of type 2 diabetes, which is known for its pronounced cardioprotectiv...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
I. Horbachevsky Ternopil National Medical University
2022-05-01
|
| Series: | Вісник медичних і біологічних досліджень |
| Subjects: | |
| Online Access: | https://bmbr.com.ua/journals/tom-12-2-2022/kardioprotektivna-diya-metforminu-pri-eksperimentalnomu-izoproterenolindukovanomu-infarkti-miokarda |